Sign in
Taking people in United StatesNo phase

Tests a diabetes education app for adults with uncontrolled type 2 diabetes

Tests a phone app with diabetes education videos in adults with type 2 diabetes.

Key facts

Who runs it
The Reading Hospital and Medical Center
Where
West Reading, United StatesSee the site
Trial code
Registry title
Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
Status
Recruiting
People taking part
65 people, planned
Started
15 Feb 2024
Planned end
30 Sept 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Diabetes education web site application
Record updated
30 July 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with type 2 diabetes whose blood sugar is not well controlled, who are patients of one family health center and have their own smartphone.

Age
18 years or older
Sex
Men and women can join.
Disease stage
Type 2 diabetes with HA1c above 8.0
Biomarker or test result
HA1c above 8.0

Main reasons for not taking part

  • Pregnancy
  • Currently incarcerated
  • No access to their own smartphone
  • Unable to give their own informed consent

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Age ≥ 18 years
  • Diagnosis of Type 2 Diabetes with HA1c >8.0
  • Current patients of the Family Healthcare Center, Reading Hospital Tower health

Who cannot take part

  • Identified special populations (pregnancy or individuals currently incarcerated)
  • Patients without access to their own smart phone
  • Any patient who is unable to provide their own informed consent to participate in the study

Where in United States

  • Reading Hospital, an affiliate of Tower HealthWest Reading, United StatesContact: Research coordinatorTaking people

About the trial

What the trial wants to find out

The goal of this clinical trial is to evaluate the use and effectiveness of a mobile web application (app) that is designed to educate and allow patients to manage diabetes and make sustainable lifestyle changes, and to study the impact of the app on clinical outcomes of diabetes (HA1C) and educational outcomes (Self-Efficacy for Diabetes Scale). The main question to answer is: Does the use of the Diabetes Application significantly affect clinical outcomes of diabetes and cardiometabolic risk factors (BMI and Blood Pressure)? Patients will be enrolled in one of two available arms of the study.

Read full original descriptionShow less

Participants in the 'intervention arm' will use the app to view educational information presented as videos in the following areas: Healthy Coping, Healthy Eating, Staying Active, Medications (Use and Safety), Problem Solving in Diabetes and Disease Pathophysiology. They will continue routine follow-up care with their primary care physicians during the study.

Participants in the 'control arm' will continue with their primary care physician in routine follow-up care, as normally scheduled.

Researchers will compare the intervention arm participants to the control arm participants to find out about and compare changes in HA1C, systolic blood pressure, diastolic blood pressure, and body mass index. Groups will also be compared on the basis of self-perceived confidence of managing their diabetes by way of the Diabetes Self Efficacy Scale.

The 2 groups in the trial

  • Intervention armTreatment being tested

    Participants enrolled in the intervention arm will be given a 6-month access period to the diabetes education application designed by the study team. The web site will offer videos related to a specific areas of education concerning diabetes self-management. To encourage compliance, participant users will receive weekly notifications from the application that will guide them through viewing all videos in the series. Participants will continue routine follow-up appointments with their primary care physicians during the study period. There will be no restrictions on starting or stopping medications during the study period.

    Treatment: Diabetes education web site application

  • Control armNo study treatment, for comparison

    Participants in the control arm will not have access to the Diabetes Application. They will continue follow-up appointments according to the standard of care with their primary care physician, diabetic educators, etc. There are no restrictions on starting or stopping medications for patients within the control arm.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluating the Clinical Impact of a PCP Developed Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
Plain-language title
Tests a diabetes education app for adults with uncontrolled type 2 diabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
30 July 2025